No Detail Found!

Ascorbic acid mitigates doxorubicin-induced spleen injury in rats: Histopathological and immunohistochemical insights

Author(s)
Arzu Gezer Vocational School of Health Services, Atatürk University, Erzurum, Turkey; Pharmaceutical Research and Development, Graduate School of Natural and Applied Sciences, Atatürk University, Erzurum, Turkey
Mustafa Ozkaraca Department of Pathology, Faculty of Veterinary Medicine, Sivas Cumhuriyet University,Sivas,Turkey
Ebru Karadağ Sari Department of Histology and Embryology, Faculty of Veterinary Medicine, Kafkas University,Kars,Turkey
Gürsel Bedir Department of Histology and Embryology, Ataturk University, School of Medicine,Erzurum,Turkey
Pelin Aydın Department of Pharmacology, Faculty of Medicine, Atatürk University,Erzurum,Turkey
Hasan Asker Department of Histology and Embryology, Faculty of Medicine, Uşak University,Uşak,Turkey
AM Abd El-Aty Department of Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey; Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt
Abstract
This study assessed the protective potential of ascorbic acid against doxorubicin-induced spleen tissue damage in rats. Twenty-eight male Sprague-Dawley rats were divided into four groups. The control group received saline every other day at a dose of 1mL throughout the experiment. The ascorbic acid group was administered 50mg/kg of ascorbic acid daily for 10 days. The doxorubicin group received a single dose of 15mg/kg of doxorubicin on day 7. The ascorbic acid + doxorubicin group received both 50mg/kg of ascorbic acid daily for 10 days and a single dose of 15mg/kg of doxorubicin on day 7. After the experiment, splenic tissue samples were examined histopathologically and immunohistochemically. Histopathological analysis revealed edema, destruction, and degeneration in the doxorubicin group, but these changes were alleviated in the ascorbic acid-treated group, approaching control group levels. Immunohistochemical analysis showed increased CD4+ and CD8+ cell immunopositivity in the ascorbic acid + doxorubicin group compared to the doxorubicin group. Biochemical tests indicated that doxorubicin reduced superoxide dismutase activity and increased malondialdehyde levels, whereas ascorbic acid mitigated these effects. The findings suggest that ascorbic acid may have a protective role against doxorubicin-induced spleen injury in rats.
Publication Details
Page(s) 591-599
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Spleen, Doxorubicin, Ascorbic Acid, CD4+, CD8+, splenotoxicity
0

Citations

0

Downloads

81

Views